[1] 世界卫生组织. 冠状病毒病(COVID-19)[EB/OL]. (2024-05-29) [2024-05-29]. https://www.who.int/zh/news-room/fact-sheets/detail/coronavirus-disease-%28covid-19%29. [2] Gandhi RT, Lynch JB, Del Rio C.Mild or moderate COVID-19[J]. N Engl J Med, 2020, 383(18): 1757-1766. [3] Carfì A, Bernabei R, Landi F.Persistent symptoms in patients after acute COVID-19[J]. JAMA, 2020, 324(6): 603-605. [4] Horberg MA, Watson E, Bhatia M, et al.Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort[J]. Nat Commun, 2022, 13(1): 5822. [5] Xu Z, Shi L, Wang Y, et al.Pathological findings of COVID-19 associated with acute respiratory distress syndrome[J]. Lancet Respir Med, 2020, 8(4): 420-422. [6] 美国疾病控制与预防中心. Long COVID or Post-COVID Conditions[EB/OL]. (2024-05-14) [2024-05-29]. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html. [7] 李琳琳,李程浩,孙文钰,等. 新型冠状病毒对人体系统影响的研究进展[J]. 华南预防医学,2024,50(6):579-582. [8] Daynes E, Gerlis C, Briggs-Price S, et al.COPD assessment test for the evaluation of COVID-19 symptoms[J]. Thorax, 2021, 76(2): 185-187. [9] 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(试行第十版)[J]. 中华临床感染病杂志,2023,16(1): 1-9. [10] Munblit D, Nicholson T, Akrami A, et al.A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: An international Delphi consensus study[J]. Lancet Respir Med, 2022, 10(7): 715-724. [11] Tartof SY, Malden DE, Liu IA, et al.Health care utilization in the 6 months following SARS-CoV-2 infection[J]. JAMA Netw Open, 2022, 5(8): e2225657. [12] Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al.More than 50 long-term effects of COVID-19: A systematic review and meta-analysis[J]. Sci Rep, 2021, 11(1): 16144. [13] Bowe B, Xie Y, Al-Aly Z.Acute and postacute sequelae associated with SARS-CoV-2 reinfection[J]. Nat Med, 2022, 28(11): 2398-2405. [14] Singh S J, Baldwin MM, Daynes E, et al.Respiratory sequelae of COVID-19: Pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation[J]. Lancet Respir Med, 2023, 11(8): 709-725. [15] Meléndez-Oliva E, Martínez-Pozas O, Cuenca-Zaldívar JN, et al.Efficacy of pulmonary rehabilitation in post-COVID-19: A systematic review and meta-analysis[J]. Biomedicines, 2023, 11(8): 2213. [16] Daynes E, Gerlis C, Chaplin E, et al.Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness, exercise capacity and cognition—A cohort study[J]. Chron Respir Dis, 2021, 18: 14799731211015691. [17] Nopp S, Moik F, Klok FA, et al.Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life[J]. Respiration, 2022, 101(6): 593-601. [18] Nalbandian A, Sehgal K, Gupta A, et al.Post-acute COVID-19 syndrome[J]. Nat Med, 2021, 27(4): 601-615. [19] 薛建华,徐德武,单雪晴,等. 新冠康复者的常见长期后遗症研究进展及健康管理对策建议[J]. 华南预防医学,2024,50(2):191-198. [20] Topol EJ, Iwasaki A. Operation nasal vaccine - lightning speed to counter COVID-19[J]. Sci Immunol, 2022, 7(74): eadd9947. |